Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO)

CUSIP: 71880W501

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
12,067,869
Total 13F shares
100,618
Share change
-53,225
Total reported value
$130,801
Price per share
$1.30
Number of holders
10
Value change
-$133,237
Number of buys
7
Number of sells
5

Security key

71880W501

Report period

Q1 2025

Institutions

10

Top holders

10

Ownership snapshot

Top shareholders of PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
CITADEL ADVISORS LLC
13D/G signal
Evidence rows
16
Latest as of
31 Dec 2024
13F 3/4/5 Lead comparable stake: 0.37% Showing first 8 of 16 holder rows. Open remaining rows
Holder Evidence Ownership % Position 12M Net Δ As of
CITADEL ADVISORS LLC
13F
Company
13F
0.37%
$80,147
44,526 shares
31 Dec 2024
HRT FINANCIAL LP
13F
Company
13F
0.35%
$76,000
42,338 shares
31 Dec 2024
Virtu Financial LLC
13F
Company
13F
0.34%
$74,000
40,910 shares
31 Dec 2024
Cetera Investment Advisers
13F
Company
13F
0.11%
$23,400
13,000 shares
31 Dec 2024
MORGAN STANLEY
13F
Company
13F
0.05%
$10,640
5,911 shares
31 Dec 2024
Tower Research Capital LLC (TRC)
13F
Company
13F
0.04%
$8,428
4,682 shares
31 Dec 2024
UBS Group AG
13F
Company
13F
0.02%
$4,315
2,397 shares
31 Dec 2024
BARCLAYS PLC
13F
Company
13F
0%
$365
203 shares
31 Dec 2024
Show 8 additional holder rows in the full holder list
Holder Evidence Ownership % Position 12M Net Δ As of
SBI Securities Co., Ltd.
13F
Company
13F
0%
$113
63 shares
31 Dec 2024
Activest Wealth Management
13F
Company
13F
0%
$16
9 shares
31 Dec 2024
BANK OF AMERICA CORP /DE/
13F
Company
13F
0%
$13
7 shares
31 Dec 2024
Gerrit Dispersyn
3/4/5
President & CEO, Director
class O/S missing
$320,614
212,327 shares
01 Mar 2022
H. Paul Dorman
3/4/5
Director
class O/S missing
$30,759
20,370 shares
15 Feb 2022
Caitlin Kontulis
3/4/5
Secretary & VP Finance & Admin
class O/S missing
$10,196
10,643 shares
01 Mar 2024
Robert M. Infarinato
3/4/5
VP, CFO
class O/S missing
$8,140
11,000 shares
11 Sep 2024
Geert Cauwenbergh
3/4/5
Director
class O/S missing
$6,395
4,235 shares
17 Feb 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
10
Shares
100,618
Rows loaded
11
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
10
Q1 2025 holders
10
Holder diff
0
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .